2025-07-10 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the provided data.

## UnitedHealth Group Inc (UNH) Analysis

**Company Overview:** UnitedHealth Group Inc. is a diversified health care company providing a wide range of products and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 19.96%
*   **VOO (S&P 500) Cumulative Return:** 94.92%
*   **Spread (UNH - VOO):** -73.1
*   **Spread Range:** Max 55.3, Min -73.1
*   **Relative Spread:** 0.0

**Analysis:** UNH significantly underperformed the S&P 500 (VOO) over the period analyzed. The spread of -73.1 indicates substantial underperformance relative to the index. The Relative Spread of 0.0 shows that UNH is at the very bottom of its historical spread range compared to VOO.

#### Alpha, Beta Analysis

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 65.0%   | 56.6%   | 36.0%   | 0.0    | 199.8  |
| 2016-2018  | 52.0%   | 63.7%   | 34.0%   | 0.0    | 225.8  |
| 2017-2019  | 38.0%   | 63.7%   | 9.0%    | 0.3    | 266.5  |
| 2018-2020  | -21.0%  | 63.7%   | -40.0%  | 0.4    | 317.9  |
| 2019-2021  | 36.0%   | 61.0%   | -13.0%  | 0.4    | 455.2  |
| 2020-2022  | 28.0%   | 66.9%   | 26.0%   | 0.4    | 480.6  |
| 2021-2023  | 33.0%   | 67.5%   | 15.0%   | 0.4    | 477.3  |
| 2022-2024  | -31.0%  | 68.6%   | -57.0%  | 0.3    | 458.6  |
| 2023-2025  | -56.0%  | 75.7%   | -103.0% | 0.2    | 274.2  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** The CAGR has fluctuated significantly, with recent periods showing negative growth.
*   **MDD (Maximum Drawdown):** MDD is consistently high, indicating substantial risk and volatility.
*   **Alpha:** Alpha has generally decreased over the period and is now strongly negative, suggesting underperformance relative to its benchmark.
*   **Beta:** Beta is low, indicating that UNH has relatively low correlation to the market.
*   **Cap(B):** Market capitalization decreased significantly in recent years.

### 2. Recent Price Movement

*   **Current Price:** 302.465
*   **Last Market Data:** {'price': 302.335, 'previousClose': 307.7, 'change': -1.74} (Down 1.74 from previous close)
*   **5-Day Moving Average:** 309.685
*   **20-Day Moving Average:** 307.7877
*   **60-Day Moving Average:** 357.9381

**Analysis:** The current price is below the 5-day, 20-day, and 60-day moving averages, indicating a recent downtrend. The fact that the last market data shows a price decrease of 1.74 further supports this downtrend.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 46.16
*   **PPO:** 0.75
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** 0.0 (Short-term decline)
*   **Expected Return:** 1242.4% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment, which is contradictory to other indicators.
*   The RSI is near the middle range, suggesting neither overbought nor oversold conditions.
*   The Hybrid Signal suggests a cautious buying strategy.
*   The Recent Relative Spread Change indicates a short-term decline relative to the S&P 500.
*   The high expected return suggests significant potential for long-term outperformance, but this must be viewed cautiously given the recent underperformance.

### 4. Recent News & Significant Events

*   **[2025-07-08]:** Business developments, regulatory changes, or market events.
*   **[2025-07-10]:** Analyst discussions on performance and outlook.
*   **[2025-07-09]:** Notable stock volatility.
*   **[2025-07-07]:** Market experts highlighting risks and opportunities.

**Analysis:** The news suggests potential volatility and uncertainty surrounding UNH, with a mix of risks and opportunities being discussed by analysts. These events should be closely monitored.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출           |
|------------|--------|----------------|
| 2025-05-07 | 6.9    | 109.58 B$      |
| 2024-11-04 | 6.56   | 100.82 B$      |
| 2024-08-09 | 4.58   | 98.86 B$       |
| 2024-05-09 | -1.53  | 99.80 B$       |
| 2025-05-07 | -1.53  | 99.80 B$       |

**Analysis:**

*   Earnings Per Share (EPS) had a negative value, but has significantly improved.
*   Revenue has been steadily increasing.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-03-31 | $109.58B    | 21.70%        |
| 2024-12-31 | $100.81B    | 21.14%        |
| 2024-09-30 | $100.82B    | 22.84%        |
| 2024-06-30 | $98.86B     | 22.31%        |
| 2024-03-31 | $99.80B     | 23.05%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE     |
|------------|-------------|---------|
| 2025-03-31 | $95.04B    | 6.62%   |
| 2024-12-31 | $92.66B    | 5.98%   |
| 2024-09-30 | $94.53B    | 6.41%   |
| 2024-06-30 | $89.36B    | 4.72%   |
| 2024-03-31 | $86.69B    | -1.63%  |

**Analysis:**

*   Revenue is showing strong growth over the past quarters.
*   Profit margins are relatively stable and healthy, around 22%.
*   Equity is increasing, and Return on Equity (ROE) has improved and is generally positive.

### 7. Comprehensive Analysis

**Summary:**

UNH has underperformed the S&P 500 significantly, especially recently, and is showing a downtrend in price. While revenue and profit margins are strong, the stock's performance compared to the index raises concerns. The financial data is relatively healthy and shows steady increases in revenue and profitability.

**Conclusion:**

The analysis paints a mixed picture. UNH demonstrates strong financials, especially in terms of revenue and profitability. However, the significant underperformance relative to the S&P 500, coupled with the recent price decline and news indicating potential volatility, suggests caution.

**Recommendations:**

*   **Monitor News and Events Closely:** Pay attention to further business developments, regulatory changes, and analyst reports.
*   **Re-evaluate Long-Term Outlook:** Consider the reasons for recent underperformance and whether they are temporary or structural.
*   **Assess Risk Tolerance:**  The high MDD and recent volatility should be carefully considered in the context of your individual risk tolerance.

